NASDAQ:YMTX Yumanity Therapeutics - YMTX Earnings Date, Estimates & Call Transcripts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Yumanity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.19 +0.03 (+0.95%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.11▼$3.4950-Day Range$3.16▼$8.3352-Week Range$0.95▼$13.23Volume9,693 shsAverage Volume473,083 shsMarket Capitalization$34.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueYMTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.YMTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.Yumanity Therapeutics Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20231($1.27)($1.27)($1.27)Q2 20231($1.33)($1.33)($1.33)Q3 20231($1.36)($1.36)($1.36) Get Yumanity Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for YMTX and its competitors with MarketBeat's FREE daily newsletter. Yumanity Therapeutics Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript8/4/2022Q2 2022($1.13)($0.45)+$0.68($0.45)$1.66 million5/12/2022Q1 2022($1.02)($1.24)($0.22)($1.24)$1.50 million$1.02 million3/24/2022Q4 2021($1.00)($1.00)($1.00)$1.81 million$0.76 million11/15/2021Q3 2021($1.13)($0.97)+$0.16($0.97)$1.93 million$1.64 million8/12/20216/30/2021($0.84)($1.03)($0.19)($1.03)$2.27 million$2.11 million5/13/20213/31/2021($0.84)($0.85)($0.01)($0.85)$1.00 million$3.53 million11/16/2020Q3 2020($3.40)($3.20)+$0.20($3.20)8/6/2020Q2 2020($4.20)($3.40)+$0.80($3.40)5/15/2020Q1 2020($4.60)($3.80)+$0.80($3.80)3/10/2020Q4 2019($5.80)($4.60)+$1.20($4.60)11/7/2019Q3 2019($8.00)($5.00)+$3.00($5.00)8/7/2019Q2 2019($7.00)($7.80)($0.80)($7.80)5/8/2019Q1 2019($8.60)($5.60)+$3.00($5.60)$0.80 million$5.00 million3/8/2019Q4 2018($9.20)($7.20)+$2.00($7.20)11/6/2018Q3 2018($9.20)($10.00)($0.80)($10.00)$0.83 million$1.06 million8/8/2018Q2 2018($8.20)($8.60)($0.40)($8.60)$1.16 million$0.84 million5/9/2018Q1 2018($10.20)($6.40)+$3.80($6.40)$1.03 million$0.94 million3/14/2018Q4 2017($13.00)($10.20)+$2.80($10.20)$1.58 million$1.62 million11/14/2017Q3 2017($12.60)($11.20)+$1.40($11.20)$1.38 million$1.55 million8/4/2017Q2 2017($12.20)($13.60)($1.40)($13.60)$1.09 million$1.15 million5/12/2017Q1 2017($11.60)($12.00)($0.40)($12.00)$1.02 million3/30/2017Q4 2016($10.20)($7.60)+$2.60($7.60)$1.71 million$4.06 million11/10/2016Q3 2016($10.00)($10.80)($0.80)($10.80)$1.72 million8/15/2016Q2 2016($8.20)($9.40)($1.20)($9.40)$1.45 million5/13/2016Q1 2016($9.40)($17.40)($8.00)($17.40)$2.44 million$1.16 millionYumanity Therapeutics Earnings - Frequently Asked Questions How much revenue does Yumanity Therapeutics generate each year? Yumanity Therapeutics (NASDAQ:YMTX) has a recorded annual revenue of $4.84 million. How much profit does Yumanity Therapeutics generate each year? Yumanity Therapeutics (NASDAQ:YMTX) has a recorded net income of -$39.50 million. YMTX has generated -$3.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: 3 Leading Dividend Stocks Expected To Grow EarningsAI Is Giving 3 Marketing & Ad Firms Revenue & Earnings BoostGeneral Mills Retreats To Buy Zone Ahead Of Earnings FedEx Is A Buy Going Into Earnings Potential Earnings Have Rated Ambrx Biopharma a Moderate BuyLemonade Earnings Gap and Crap. Here’s Why.Is Unity Software Earnings Fallout a Buying Opportunity? Upcoming Earnings: BlackRock (4/12/2023)Infosys (4/12/2023)Progressive (4/13/2023)Taiwan Semiconductor Manufacturing (4/13/2023)U.S. Bancorp (4/13/2023)Wells Fargo & Company (4/13/2023)Citigroup (4/14/2023)JPMorgan Chase & Co. (4/14/2023)The PNC Financial Services Group (4/14/2023)UnitedHealth Group (4/14/2023) This page (NASDAQ:YMTX) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.